Bayer AG and Johnson & Johnson agreed to pay $775 million to settle more than 25,000 U.S. lawsuits tied to their blood thinner Xarelto, according to Reuters.
Pharmacy
Eli Lilly, facing political pressure for the skyrocketing list price of a widely used insulin treatment, released a report March 25 claiming the price it was paid for insulin dropped by 8.1 percent in the last five years after rebates…
The billionaire Sackler family has become more involved recently in settlement talks to resolve more than 1,600 lawsuits claiming its Purdue Pharma helped fuel the nation's opioid epidemic, according to The Wall Street Journal.
Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.
The House Oversight Committee asked Oxycontin-maker Purdue Pharma to hand over several documents that may help uncover more about the Sacklers, the billionaire family that owns the company, according to STAT.
Congressional approval for President Donald Trump's revised North American Free Trade Agreement may hinge on a small provision that governs patent protections for drugmakers, according to The New York Times.
After a two-year legal battle, Dr. Reddy's Laboratories has won the right to sell a cheaper version of a best-selling opioid addiction treatment in the U.S., according to Bloomberg.
Executives from five major pharmacy benefit managers have agreed to testify at a Senate Finance Committee hearing on high drug costs in April, according to The Hill.
Kentucky Attorney General Andy Beshear is investigating allegations that pharmacy benefit managers overcharged state health insurers for drugs and discriminated against independent pharmacies, Reuters reports.
Roche has sued more than a dozen former executives at Alliance Medical Holdings over what the drugmaker calls fraudulent schemes involving its diabetes test strips, according to Reuters.